rs326214

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000706887.1(MADD):​c.1041G>A​(p.Glu347Glu) variant causes a synonymous change. The variant allele was found at a frequency of 0.64 in 1,613,686 control chromosomes in the GnomAD database, including 338,758 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 26060 hom., cov: 31)
Exomes 𝑓: 0.65 ( 312698 hom. )

Consequence

MADD
ENST00000706887.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.77

Publications

51 publications found
Variant links:
Genes affected
MADD (HGNC:6766): (MAP kinase activating death domain) Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
MADD Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 11-47276809-G-A is Benign according to our data. Variant chr11-47276809-G-A is described in ClinVar as Benign. ClinVar VariationId is 1243998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MADDNM_001376571.1 linkc.1041G>A p.Glu347Glu synonymous_variant Exon 5 of 37 NP_001363500.1
MADDNM_003682.4 linkc.1041G>A p.Glu347Glu synonymous_variant Exon 5 of 36 NP_003673.3 Q8WXG6-1
MADDNM_001376572.1 linkc.1041G>A p.Glu347Glu synonymous_variant Exon 5 of 37 NP_001363501.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MADDENST00000706887.1 linkc.1041G>A p.Glu347Glu synonymous_variant Exon 5 of 37 ENSP00000516604.1 A0A9L9PXF1

Frequencies

GnomAD3 genomes
AF:
0.565
AC:
85830
AN:
151888
Hom.:
26041
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.356
Gnomad AMI
AF:
0.826
Gnomad AMR
AF:
0.623
Gnomad ASJ
AF:
0.756
Gnomad EAS
AF:
0.308
Gnomad SAS
AF:
0.532
Gnomad FIN
AF:
0.571
Gnomad MID
AF:
0.709
Gnomad NFE
AF:
0.684
Gnomad OTH
AF:
0.632
GnomAD2 exomes
AF:
0.593
AC:
149049
AN:
251424
AF XY:
0.603
show subpopulations
Gnomad AFR exome
AF:
0.348
Gnomad AMR exome
AF:
0.551
Gnomad ASJ exome
AF:
0.763
Gnomad EAS exome
AF:
0.294
Gnomad FIN exome
AF:
0.578
Gnomad NFE exome
AF:
0.688
Gnomad OTH exome
AF:
0.666
GnomAD4 exome
AF:
0.647
AC:
946136
AN:
1461680
Hom.:
312698
Cov.:
50
AF XY:
0.647
AC XY:
470119
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.356
AC:
11903
AN:
33480
American (AMR)
AF:
0.562
AC:
25153
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.763
AC:
19936
AN:
26130
East Asian (EAS)
AF:
0.307
AC:
12192
AN:
39696
South Asian (SAS)
AF:
0.537
AC:
46324
AN:
86244
European-Finnish (FIN)
AF:
0.588
AC:
31386
AN:
53382
Middle Eastern (MID)
AF:
0.708
AC:
4086
AN:
5768
European-Non Finnish (NFE)
AF:
0.680
AC:
756614
AN:
1111870
Other (OTH)
AF:
0.638
AC:
38542
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
16541
33082
49622
66163
82704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19096
38192
57288
76384
95480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.565
AC:
85898
AN:
152006
Hom.:
26060
Cov.:
31
AF XY:
0.559
AC XY:
41494
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.357
AC:
14782
AN:
41440
American (AMR)
AF:
0.624
AC:
9521
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.756
AC:
2622
AN:
3468
East Asian (EAS)
AF:
0.307
AC:
1591
AN:
5182
South Asian (SAS)
AF:
0.533
AC:
2562
AN:
4808
European-Finnish (FIN)
AF:
0.571
AC:
6025
AN:
10560
Middle Eastern (MID)
AF:
0.707
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
0.684
AC:
46492
AN:
67962
Other (OTH)
AF:
0.636
AC:
1342
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1732
3464
5196
6928
8660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.649
Hom.:
99743
Bravo
AF:
0.561
Asia WGS
AF:
0.459
AC:
1600
AN:
3478
EpiCase
AF:
0.707
EpiControl
AF:
0.712

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 05, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Deeah syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
7.2
DANN
Benign
0.80
PhyloP100
4.8
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs326214; hg19: chr11-47298360; COSMIC: COSV60628604; COSMIC: COSV60628604; API